Skip to main content
. 2016 Sep 29;11(9):e0163138. doi: 10.1371/journal.pone.0163138

Fig 3. Hydrophobic mutations adversely affect patient DFS.

Fig 3

Analysis was conducted in non-LPBC (tumors with <50% TILs). LN in B: nodal status. Patients with tumors with hydrophobic mutations performed worse in every context, in both cohorts.